Deals of the day-Mergers and acquisitions

Axonics

08/01/2024 11:05

(Adds J&J, Boston Scientific; updates Merck & Co)
       Jan 8 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1650 GMT on Monday:

        ** Johnson & Johnson  JNJ.N  said it had agreed to buy
drug developer Ambrx Biopharma  AMAM.O  for $2 billion to gain
access to drugs that belong to a class of targeted cancer
therapies which have drawn interest from other drugmakers.
 urn:newsml:reuters.com:*:nL4N3DY280
  
        
  
        ** Medical device maker Boston Scientific  BSX.N  said
it had agreed to buy Axonics Inc  AXNX.O  for $3.7 billion,
gaining access to devices used to improve bladder function.
 urn:newsml:reuters.com:*:nL4N3DY23G
  
        
  
        ** Merck & Co  MRK.N  said it would buy cancer drug
developer Harpoon Therapeutics  HARP.O  for about $680 million,
reinforcing its oncology portfolio with immunotherapies.
 urn:newsml:reuters.com:*:nL4N3DY27X
  

    ** The head of France's biggest supermarket chain E. Leclerc
said it was still selling Pepsi after rival Carrefour  CARR.PA 
ditched PepsiCo  PEP.O  products in the latest tug-of-war
between retailers and global food giants over prices.
 urn:newsml:reuters.com:*:nL8N3DY1DK
    
    ** Malaysia's Capital A Berhad  CAPI.KL  said it intends to
sell its aviation business to long-haul unit AirAsia X Bhd
 AIRX.KL , with a goal of consolidating both its long and
short-haul operations under a single AirAsia brand.  urn:newsml:reuters.com:*:nL4N3DY0RW

 (Compiled by Rajarshi Roy and Christy Santhosh in Bengaluru)
 ((Rajarshi.Roy@thomsonreuters.com;))